002173 创新医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-3.107-1.977-5.153-1.817-3.783
总资产报酬率 ROA (%)-2.499-1.590-4.189-1.484-3.007
投入资产回报率 ROIC (%)-2.813-1.805-4.771-1.691-3.430

边际利润分析
销售毛利率 (%)1.4396.9097.80511.4464.310
营业利润率 (%)-15.811-3.913-7.394-3.183-11.075
息税前利润/营业总收入 (%)-16.115-3.621-12.666-5.917-12.053
净利润/营业总收入 (%)-16.194-4.641-11.518-4.256-10.370

收益指标分析
经营活动净收益/利润总额(%)104.560247.94459.32165.472112.334
价值变动净收益/利润总额(%)-2.867-127.848-1.9685.257-4.524
营业外收支净额/利润总额(%)1.956-5.83140.04726.670-4.410

偿债能力分析
流动比率 (X)1.8521.8381.8642.2532.394
速动比率 (X)1.7471.7151.7342.1242.241
资产负债率 (%)18.88619.03119.36717.98818.577
带息债务/全部投入资本 (%)5.3413.3663.2062.3751.823
股东权益/带息债务 (%)1,687.9492,700.5342,861.6303,931.3775,086.934
股东权益/负债合计 (%)426.445421.968416.119455.706438.085
利息保障倍数 (X)-1,431.269-47.33937.9683.7538.336

营运能力分析
应收账款周转天数 (天)40.78049.27850.07834.49934.219
存货周转天数 (天)18.49119.38320.05322.97624.463